<DOC>
	<DOCNO>NCT02786082</DOCNO>
	<brief_summary>The main objective study pharmacokinetics Azilsartan Tablets human provide evidence clinical study clinical application product .</brief_summary>
	<brief_title>Pharmacokinetics Study Azilsartan Tablets Chinese Healthy Volunteers</brief_title>
	<detailed_description>This Single center , randomize , open label study . The study conduct evaluate pharmacokinetics Studies Azilsartan single-dose oral administration , multiple-dose oral administration effect diet . 1 ) Pharmacokinetics Studies Azilsartan Single-dose oral administration : 24 healthy subject randomly divide 2 group evenly , Group I Group II , 12 subject group , half male half female . Group I take Azilsartan tablet 20mg orally fasting , Group II take Azilsartan tablet 40mg orally fast . Blood sampling time : 0h ( administration start ) , 0.25 , 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 5 , 6 , 8 , 10 , 12 , 16 , 24 , 36 , 48h administration . 5ml whole blood cubital vein place heparinized tube centrifuge . Duplicated plasma A B take keep low temperature . 2）Pharmacokinetic Studies Azilsartan Tablets Multiple-dose oral administration Subjects Group I take 20mg Azilsartan orally daily 7 day ( day 3~day 9 ) complete last time blood sample collection ( day 2 , 48h ) first time administration ( day 1 ) . 5mL blood sample collect vein day 7 , day 8 day 9 measure minimum observed concentration drug administration . On day 9 , administration , blood sampling time single-dose administration study . Blood sampling time : 0h ( administration start ) , 0.25 , 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 5 , 6 , 8 , 10 , 12 , 16 , 24 , 36 , 48h administration . 5ml whole blood cubital vein place heparinized tube centrifuge . Duplicated plasma A B take keep low temperature . 3）The effect diet pharmacokinetic study : The 12 healthy subject , group II ( single-dose administration study ) , 7-day washout period first administration ( day 1 , 40mg ) receive Azilsartan tablet 40mg high-fat diet day 8 , blood sampling time point administration single-dose administration study . The process , storage condition blood sample single-dose administration study . Blood sampling time : 0h ( administration start ) , 0.25 , 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 4 , 5 , 6 , 8 , 10 , 12 , 16 , 24 , 36 , 48h administration . 5ml whole blood cubital vein place heparinized tube centrifuge . Duplicated plasma A B take keep low temperature .</detailed_description>
	<criteria>1 . Subjects group adult female adult male 18 45 ( inclusive ) year age , year age difference subject 10 . 2 . Body mass index ( BMI ) within range 19~25kg/m2 ( inclusive ) . BMI=weight ( kg ) /height ( ) 2。 3 . Subjects eligible participate result physical examination （height , weight , respiration , pulse , blood pressure , thorax , abdomen , etc） laboratory examination ( blood routine examination , urine routine test , blood chemistry test , infectious disease screening , etc ) normal , test conduct subject trial initiating . The result ECG chest Xray normal slightly abnormal without clinical significance . 4 . Subjects history cardiovascular disease , liver disease , renal disease , digestive disease , psychiatric disease , neuropathy disease , etc . 5 . Subjects allergic history Angiotensin Receptor Blockers , drug biological agent . 6 . Subjects addict smoke alcohol without bad habit . 7 . Subjects participate clinical trial donate blood within 3 month prior trial , 8 . Subjects well know nature , significance , possible benefit , inconvenience potential risk participate trial understood trial process . Subjects voluntary participate trial . 1 . Subjects abnormalities clinical significance physical examination , laboratory examination , 12lead ECGs , chest Xray . 2 . Subjects history orthostatic hypotension , gastrointestinal disease ( gastric ulcer , gastritis , etc ) , renal disease ( nephritis , nephropyelitis , etc ) , cardiovascular , respiratory , neurological , psychotic , haematological , endocrine disorder . 3 . Subjects allergic constitution history sensitivity Angiotensin Receptor Blockers history drug biological agent . 4 . Systolic blood pressure ( SBP ) &lt; 90mmHg &gt; 140mmHg , and/or diastolic blood pressure ( DBP ) &lt; 50mmHg &gt; 90mmHg . Subjects orthostatic hypotension ( screen , symptomatic asymptomatic orthostatic hypotension define : subject lie comfortably 5 minute , blood pressure record 5 min consider baseline . The time point subject stand consider onset time . Orthostatic hypotension diagnose rise systolic blood pressure 20mmHg , decrease diastolic blood pressure 20mmHg , stand arm relax ) . 5 . Vegetarian . 6 . Subjects plan bear child 6 month . 7 . History alcohol abuse last 6 month prior screen define average weekly intake great 14 unit ( one unit equivalent 360ml beer 45ml spirit 40 % alcohol content 150 ml wine ) . History smoke &gt; 5 cigarette day last 6 month prior screen . 8 . History administrate drug effect trial . Subjects participate donation blood drug clinical trial ( subject ) last 3 month , take drug . 9 . Hepatitis B patient , Hepatitis C patient , hepatitis C carrier , subject immunodeficiency , positive HIV antibody result , positive syphilis antibody result . 10 . 72 hour prior randomization , subject history special diet ( include grapefruit , xanthine diet , chocolate , caffeinated coffee tea , caffeinated beverage ) strenuous exercise , factor effect absorption , distribution , metabolism excretion . 11 . Subjects take prescription drug 2 week study . 12 . Subjects , opinion investigator , participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>